CADTH provided updates on its Scientific Advice program and Post-Market Drug Evaluation. CIOMS shared a report on using real-world data in decision-making. CDA-TO sought input on drug analytics. The committee discussed its mandate and membership for future meetings.

0 views • 5 slides

This material discusses the challenges and advancements in the rapid development of new medicines, emphasizing the importance of education for healthcare professionals. It provides insights into the medicinal products lifecycle, current trends in research and development, and aligning educational ne

0 views • 4 slides